When a foodborne illness outbreak occurs, public communication is not separate from the response. It is part of the response.
Clear, timely information can help consumers avoid a specific risk and help the supply chain remove affected food. Vague, incomplete or inconsistent information can do the opposite: confuse consumers, obscure the actual risk and reduce confidence in foods that were never implicated. The U.S. Food and Drug Administration faces a difficult task. Outbreak investigations develop quickly; early investigative evidence does not always lead to a single food source, and waiting for certainty can leave people exposed. Thus, the communication challenge is apparent. The answer, though, is not to communicate less. It is to communicate with greater precision, context, coordination and transparency about uncertainty.
The 2026 Cyclospora outbreak illustrates why this matters. On July 4, the Michigan Department of Health and Human Services reported that no grower, supplier or produce type had been identified. Yet its advisory listed six types of produce associated with previous Cyclospora outbreaks and recommended that restaurants and consumers alter how they purchased or prepared them. Those foods included salad mixes, cilantro, basil, raspberries, snow peas and green onions. The state was appropriately trying to protect consumers during a rapidly growing outbreak. But listing commodities from earlier outbreaks, without evidence that they were involved in the current event, created a predictable risk: the public and news media could interpret historical examples as a list of suspects. This was a missed opportunity for FDA to provide a visible, coordinating federal voice that distinguished three things: what investigators knew, what they were evaluating and what consumers could do without avoiding broad categories of nutritious food.
On July 16, FDA and CDC announced that a subset of illnesses was linked to shredded iceberg lettuce served at Taco Bell restaurants and that traceback converged on a supplier in Mexico. FDA identified Taylor Farms de Mexico the following day, along with the voluntary removal and recall. That specificity was essential. It gave consumers, retailers and restaurants an actionable target and clarified that the evidence did not implicate all lettuce, all leafy greens or all fresh produce. During that period, FDA could have maintained a central national update explaining that there were several additional Cyclospora clusters under investigation, that no single produce item explained all reported illnesses and that domestic leafy greens had not been implicated by the available evidence. FDA did not need to disclose confidential traceback information or overstate preliminary findings. It needed to explain the boundaries of the evidence it had at hand.
North Carolina offered another example of why federal coordination matters. On July 17, state officials reported that parsley, cilantro and lettuce were commonly reported among cases there, while expressly noting that the North Carolina increase did not appear connected to the Taco Bell outbreak and that exposure reports did not prove causation. Those distinctions were important, but consumers following national headlines could easily combine separate state announcements into one expanding list of risky produce. FDA should serve as the authoritative hub that clearly separates confirmed outbreaks, suspected clusters, unrelated investigations and background surveillance.
The handling of a product sample on July 18 and 19 showed another communication vulnerability. FDA announced a positive Cyclospora result from lettuce supplied by Taylor Farms de Mexico, then reported the next day that laboratory review found the result was a false positive. FDA appropriately corrected the record and explained that the epidemiological and traceback evidence still supported the recall. However, preliminary laboratory findings with significant public and commercial consequences should undergo a defined verification step before public release whenever consumer protection does not require immediate disclosure. When a correction is necessary, it should be as prominent and widely distributed as the original announcement—not merely edited into a webpage. FDA’s current outbreak page provides a useful update history, but the goal should be to prevent unverified findings from shaping the initial news cycle. These are not isolated concerns. Western Growers’ analysis of the 2022 hepatitis A outbreak linked to imported strawberries found an estimated $125 million in short-term wholesale revenue losses for California growers, even though domestic strawberries were not recalled. The initial public health advisory did not clearly identify the product as imported. That detail mattered not only to growers. When consumers cannot tell which product is affected, they may avoid an entire category. Reduced fruit and vegetable consumption is itself a public health concern.
FDA can improve outbreak communication through a practical framework.
First, every advisory should state, in plain language, what is confirmed, what is reasonably suspected, what remains unknown and what would change the agency’s assessment. FDA already says that a public health advisory should provide specific, actionable steps. The same standard should apply to descriptions of risk and uncertainty.
Second, as soon as evidence permits, FDA should identify the commodity, product form, brand or supplier, country and growing region of origin, distribution channel and relevant dates. If those details are unknown, the advisory should say so explicitly and explain what investigators are doing to obtain them.
Third, FDA should coordinate messaging with CDC and state health and agriculture agencies before major announcements. A short joint risk-communication call can reduce contradictory wording without delaying urgent warnings. Federal updates should also clearly distinguish concurrent clusters. Federal updates should also clearly distinguish concurrent clusters by providing information on why these clusters are considered distinct, what food sources are reasonably being considered, including country of origin, and how each cluster’s case count contributes to the total case count.
Fourth, FDA should build correction discipline into its outbreak process. Material changes should be time-stamped, preserved in an update history, pushed through the same media and subscriber channels as the original statement and accompanied by a concise explanation of why the evidence changed. Finally, communication should continue after the immediate hazard has passed. FDA should publish timely outbreak investigation and root-cause reports that translate findings into preventive actions for growers, importers, retailers and public health agencies. A collaborative approach should also extend to outbreak communication protocols, using pre-established contacts with commodity experts who can help the agency describe seasonal production, product forms and supply-chain distinctions accurately.
FDA has made meaningful progress. Its current outbreak pages provide case counts, product-distribution information, recall details and dated updates. The agency has also emphasized actionable advice as the basis for public health advisories. The next step is to make transparency, uncertainty, origin and correction equally consistent features of every communication. Consumers deserve prompt warnings when food may be unsafe. They also deserve to know what food is not implicated, how strong the evidence is and when the facts change. Better communication will not eliminate outbreaks, but it will help protect people without creating avoidable confusion, undermining confidence in fresh produce or discouraging the healthy eating that public health agencies work to promote.